Patents by Inventor David Braun Kanne

David Braun Kanne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Locked nucleic acid cyclic dinucleotide compounds and uses thereof
    Patent number: 11098077
    Abstract: The present invention provides highly active locked nucleic acid cyclic-dinucleotide (LNA-CDN) immune stimulators that activate DCs via the cytoplasmic receptor known as STING (Stimulator of Interferon Genes). In particular, the LNA-CDNs of the present invention are provided in the form of a composition comprising one or more cyclic dinucleotides that induce human STING-dependent type I interferon production, wherein the cyclic dinucleotides present in the composition have at least one 2?, 4? locked nucleic acids within the cyclic dinucleotide.
    Type: Grant
    Filed: July 1, 2017
    Date of Patent: August 24, 2021
    Assignees: CHINOOK THERAPEUTICS, INC., NOVARTIS AG
    Inventors: David Braun Kanne, Chudi Obioma Ndubaku, Jacob Robert Bruml, Thanh Ngoc Lan Le, Jeffrey McKenna, George Scott Tria, Stephen Canham
  • LOCKED NUCLEIC ACID CYCLIC DINUCLEOTIDE COMPOUNDS AND USES THEREOF
    Publication number: 20190185511
    Abstract: The present invention provides highly active locked nucleic acid cyclic-dinucleotide (LNA-CDN) immune stimulators that activate DCs via the cytoplasmic receptor known as STING (Stimulator of Interferon Genes). In particular, the LNA-CDNs of the present invention are provided in the form of a composition comprising one or more cyclic dinucleotides that induce human STING-dependent type I interferon production, wherein the cyclic dinucleotides present in the composition have at least one 2?, 4? locked nucleic acids within the cyclic dinucleotide.
    Type: Application
    Filed: July 1, 2017
    Publication date: June 20, 2019
    Applicants: ADURO BIOTECH, INC., NOVARTIS AG
    Inventors: David Braun KANNE, Chudi Obioma NDUBAKU, Jacob Robert BRUML, Thanh Ngoc Lan LE, Jeffrey MCKENNA, George Scott TRIA, Stephen CANHAM
  • Microcapsules
    Patent number: 8173159
    Abstract: A novel microcapsule comprising an encapsulated material which is enclosed within a solid permeable shell of a polymer resin having surface modifying compounds capable of reacting with isocyanate incorporated therein is disclosed. The process for producing such microcapsules is likewise disclosed.
    Type: Grant
    Filed: June 5, 2001
    Date of Patent: May 8, 2012
    Assignee: Syngenta Limited
    Inventors: Herbert Benson Scher, Jinling Chen, Isabelle Mazeaud, David Braun Kanne, Ian Malcolm Shirley, Philip Wade, John Christopher Padget, Anne Waller
  • Novel microcapsules
    Publication number: 20020136773
    Abstract: A novel microcapsule comprising an encapsulated material which is enclosed within a solid permeable shell of a polymer resin having surface modifying compounds capable of reacting with isocyanate incorporated therein is disclosed. The process for producing such microcapsules is likewise disclosed.
    Type: Application
    Filed: June 5, 2001
    Publication date: September 26, 2002
    Inventors: Herbert Benson Scher, Jinling Chen, Isabelle Mazeaud, David Braun Kanne, Ian Malcolm Shirley, Philip Wade, John Christopher Padget, Anne Waller